Research Article
Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration
Table 1
Experimental groups.
| Animal group | Number of cochleae (animals) | ADAC dosage | Administration route | Sample type | Collection period (min) |
| Control | 22 (12) | 100 µg/kg | Intravenous | Perilymph | 120 | Noise exposed | 31 (17) | 100 µg/kg | Intravenous | Perilymph | 120 |
|
|